Lung cancer is a disease in which the cells of the lung tissue grow uncontrollably and form tumors. Lung cancer occurs mostly in people between the ages of 45 and 70 and is difficult to detect. Only 15% of lung cancer cases are detected in the early stages. Because of late detection, survival rates are low.
Treating non-small cell lung cancer has proven difficult even in its early stages. Through surgery, tumors can be removed, but not many survive.
Subsequently, the medical profession realized that if chemotherapy is given immediately after surgery, the survival rate of non-small cell lung cancer patients improves.
A drug called PF-02341066 has been invented to treat non-small cell lung cancer, called anaplastic lymphoma kinase (ALK). PF-02341066 works in the treatment of lung cancer by blocking cell growth and the migration and invasion of tumor cells.
Another new treatment for lung cancer is the L C Detect. LC Detect® is an in vitro serum test to aid in the detection of lung cancer. LC Detect® provides diagnostic information about lung cancer by measuring the level of HAAH in the serum. A higher level of serum, HAAH in a patient conveys that further diagnostic evaluations may be necessary to determine the presence of lung cancer.
In yet another advancement to remove cancerous cells, three small incisions are made and special instruments are inserted into the body to reach the lungs. A camera then guides the doctor to the tumor.
© Newsmax. All rights reserved.